Skip to main content
Erschienen in: International Urogynecology Journal 7/2022

13.04.2022 | Original Article

Endometrial cancer after the Manchester procedure: a nationwide cohort study

verfasst von: Karen R. Husby, Kim O. Gradel, Niels Klarskov

Erschienen in: International Urogynecology Journal | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

We aimed to investigate whether the Manchester procedure affects the risk and prognosis of endometrial cancer.

Methods

All Danish residents have a personal number permitting linkage of nationwide registers on the individual level enabling epidemiological studies with lifelong follow-up. We performed a nationwide historical cohort study including Danish women born before 2000 undergoing the Manchester procedure (N = 23,935) during 1977–2018. We included women undergoing anterior colporrhaphy as a reference group (N = 51,008) because of comparable inclination to consult a doctor and clinical similarities. Main outcomes were the number of women diagnosed with endometrial cancer, the stage of endometrial cancer at time of diagnosis, and cancer-specific and overall mortality. We followed the cohort until endometrial cancer/death/emigration/hysterectomy/31 December 2018. We performed chi-square test for trend to compare the diagnostic stage and Cox regressions to analyze the risk of endometrial cancer and mortality. The models were adjusted for age, calendar year, income level, and parity.

Results

During follow-up (median 13 years), 271 (1.13%) women were diagnosed with endometrial cancer after the Manchester procedure and 520 (1.05%) after anterior colporrhaphy. The adjusted hazard ratio (HR) for endometrial cancer was 1.00 [95% confidence interval (CI) 0.86–1.16]. No difference in stage of cancer was found (p = 0.18) nor when stratifying for calendar year. The HR for cancer-specific mortality and overall mortality after the Manchester procedure was 0.87 (95% CI 0.65–1.16) and 0.93 (95% CI 0.77–1.12), respectively.

Conclusions

The Manchester procedure does not affect the risk or prognosis of endometrial cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat Madsen AM, Raker C, Sung VW. Trends in Hysteropexy and Apical Support for Uterovaginal Prolapse in the United States from 2002 to 2012. Female Pelvic Med Reconstr Surg. 2017;23:365–71.CrossRef Madsen AM, Raker C, Sung VW. Trends in Hysteropexy and Apical Support for Uterovaginal Prolapse in the United States from 2002 to 2012. Female Pelvic Med Reconstr Surg. 2017;23:365–71.CrossRef
14.
Zurück zum Zitat Cardozo L, Staskin D, Schuessler B, et al. Preservation of the prolapsed uterus, chapter 75. In: Textbook of Female Urology and Urogynecology, second edition, Section 8, Surgery for urogenital prolapse. 2006, pp 1079–1080. Cardozo L, Staskin D, Schuessler B, et al. Preservation of the prolapsed uterus, chapter 75. In: Textbook of Female Urology and Urogynecology, second edition, Section 8, Surgery for urogenital prolapse. 2006, pp 1079–1080.
18.
29.
Zurück zum Zitat Tripton RH, Atkin PF. Uterine disease after the Manchester repair operation. J Obstet Gynecol Br Commonw. 1970;77:852–3.CrossRef Tripton RH, Atkin PF. Uterine disease after the Manchester repair operation. J Obstet Gynecol Br Commonw. 1970;77:852–3.CrossRef
Metadaten
Titel
Endometrial cancer after the Manchester procedure: a nationwide cohort study
verfasst von
Karen R. Husby
Kim O. Gradel
Niels Klarskov
Publikationsdatum
13.04.2022
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 7/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-022-05196-4

Weitere Artikel der Ausgabe 7/2022

International Urogynecology Journal 7/2022 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.